PMGC Holdings Inc. 8-K Filings

PMGC Holdings Inc. (Nasdaq: ELAB) reported several corporate actions, including effecting a previously approved 1‑for‑10 reverse stock split of its common stock on August 21, 2026. At the effective time, every 10 issued and outstanding common shares were automatically combined into 1 share, with no fractional shares issued; holders received one whole share in lieu of any fraction. Authorized capital is now 508,333,334 shares, consisting of 8,333,334 common and 500,000,000 preferred shares, and the stock continues trading on Nasdaq under the symbol ELAB on a split‑adjusted basis.

The company entered into an Exchange Agreement with Streeterville Capital LLC to exchange a Secured Pre‑Paid Purchase #2 for 80,000 common shares, leaving an outstanding balance of $1,071,339.8 on that instrument after a small partitioned amount. PMGC also signed a non‑binding term sheet with Orbit2Orbit for a three‑part relationship involving space‑based mouse studies using its EL‑22 and EL‑32 assets, a preferred U.S. manufacturing role for subsidiary A&B Aerospace, and a proposed CAD $200,000 equity subscription at CAD $0.80 per share. Separately, PMGC terminated a non‑binding LOI to acquire a 76% stake in an Arizona precision machining company after audit‑stage due diligence, incurring no breakup fee, and entered a trademark license with an affiliate of its chairman to use the “NorthStrive” marks.

PMGC Holdings Inc., through its wholly owned subsidiaries, entered into a Merger Agreement to combine AGA Precision Systems LLC with A&B Aerospace, Inc. AGA will merge into A&B, with A&B as the surviving entity.

All membership interests in AGA will be cancelled without consideration, while all issued and outstanding shares of A&B will remain outstanding and unchanged. The merger will be completed upon filing a Certificate of Merger with the California Secretary of State, with an anticipated effective date of July 2, 2026.

PMGC Holdings Inc., through its wholly owned subsidiary NorthStrive Defense Tech LLC, entered into a Standard Exclusive License Agreement effective June 30, 2026. The deal grants a worldwide, non-transferable, exclusive license to make, use, and sell products covered by U.S. Patent No. 12,291,334 and related know-how in aerospace and defense technologies, with rights to grant sublicenses.

NorthStrive Defense Tech must follow a development plan, provide detailed annual progress reports, and meet diligence milestones, with failure potentially constituting a material breach unless extensions are granted. Consideration includes a non-refundable license issue fee, annual maintenance fees until first Net Sales, ongoing royalties, and sublicense payments over a product- and country-specific Royalty Term that lasts until patent expiry or twelve years from first Net Sale, whichever is later.

The License Agreement includes termination rights for both parties, including nonpayment, uncured breaches, repeated payment defaults, and insolvency events. Key definitions cover Know-How, Licensed Products, Patent Rights, and Royalty Term, and the full agreement is filed as Exhibit 10.1.

PMGC Holdings Inc., through subsidiary NorthStrive Biosciences, reported positive Phase III results from its AI-driven drug discovery program with Yuva Biosciences.

Four AI-selected small molecules (C1–C4) significantly increased ANT1 protein expression in primary human skeletal muscle cells, with dose-dependent gains up to 50%. The partners plan confirmatory testing in a more mature skeletal muscle model to validate ANT1 induction as part of PMGC’s broader muscle-preservation strategy, including potential use alongside GLP-1 weight-loss treatments. The company emphasizes these in vitro findings are preliminary and subject to substantial development, regulatory and commercial risks.

PMGC Holdings Inc., which trades on Nasdaq under the symbol ELAB, reported results from its 2026 Annual Meeting and a key change to its corporate governance. Shareholders approved amended bylaws that classify the Board of Directors into two staggered classes, Class I and Class II, with different term lengths.

The staggered structure will start after the 2027 Annual Meeting. Initial Class I directors will serve until the 2030 Annual Meeting, and initial Class II directors will serve until the 2028 meeting. At the 2026 Annual Meeting, all five director nominees were elected with about 99.8% of votes cast, and shareholders also approved the staggered board proposal and ratified HTL International, LLC as auditor for the 2026 fiscal year. A quorum was present, with 6,564,834 shares represented, or 60.13% of 10,916,625 outstanding shares entitled to vote.

PMGC Holdings Inc., through its subsidiary NorthStrive Defense Tech LLC, entered into a binding term sheet with the Florida State University Research Foundation to obtain an exclusive, worldwide, sublicensable license to patent rights related to U.S. Patent No. 12,291,334 for aerospace and defense technologies. The license includes tiered earned royalties on net sales by product category and cumulative net sales, an annual minimum royalty, a sublicensing revenue share, and an annual maintenance fee, while PMGC follows a multi-year development plan that can be adjusted by mutual agreement.

NorthStrive Defense Tech also signed an Educational Research Agreement with the Florida State University Research Foundation under which it will fund $490,657 of research by the Center for Intelligent Systems, Control, and Robotics over a 12‑month term starting June 1, 2026. Any inventions made during the research will belong to the foundation, with NorthStrive Defense Tech receiving an option to negotiate a royalty-bearing license and a royalty‑free, non‑exclusive internal use license, and either party may terminate the research agreement with 30 days’ written notice.

PMGC Holdings Inc. completed the acquisition of 100% of A&B Aerospace, Inc. for $4.5 million in cash, paying $4.275 million at closing and retaining $225,000 as an indemnification holdback tied to specific litigation. The price is subject to cash and net working capital adjustments after closing.

A&B Aerospace is a precision CNC machining contractor serving aerospace, defense, and industrial markets. It generated $4.28 million of revenue and a $0.11 million net loss in the year ended May 31 2025, and $3.61 million of revenue with $0.34 million net income for the nine months ended February 28 2026. As of February 28 2026, it reported total assets of $2.41 million, cash of $0.68 million, investments of $0.34 million, and net working capital of about $1.45 million, indicating a solid liquidity position.

PMGC Holdings Inc., through its wholly owned subsidiary NorthStrive Biosciences Inc., reported that NorthStrive has filed a new U.S. patent application covering its EL-22 myostatin-engineered probiotic for human pharmaceutical use. The application (U.S. Application No. 19/655,160) focuses on formulated products, dosing regimens and protections for treating a broad range of muscle-wasting conditions, including sarcopenia, muscle disuse atrophy and certain neurological disorders. This filing builds on earlier EL-22 intellectual property aimed at muscle preservation and growth, including in patients receiving GLP-1 receptor agonist weight-loss treatments, and is intended to strengthen NorthStrive’s muscle health therapeutics portfolio.

PMGC Holdings Inc., through its wholly owned subsidiary NorthStrive Defense Tech LLC, furnished information that the subsidiary has secured an exclusive option agreement on a proprietary, U.S.-patented autonomous drone navigation technology for GPS-jammed, spoofed, and denied environments.

The option covers an exclusive license in the aerospace and defense technologies field for specified patent rights tied to U.S. Patent No. 12,277,716 B2, plus a non-exclusive license to related know-how. NorthStrive plans to evaluate the technology, validate defense and counter-drone use cases, and may negotiate a definitive licensing agreement, though there is no guarantee the option will be exercised or that commercialization will succeed.

PMGC Holdings Inc., through its subsidiary SVM Machining, Inc., filed an 8-K to share a press release about a new long-term supply agreement with Turbo-Jet Products Co., Inc. SVM will supply mission-critical aerospace and defense components under a framework covering purchase orders during the agreement’s term.

The agreement has an initial five-year term with provisions for annual renewals, supporting a strategic supply relationship. This is the third long-term agreement signed by a PMGC subsidiary in 2026. SVM is ITAR-registered as of March 20, 2026 and is pursuing AS9100 certification to expand its role in regulated defense programs.

PMGC Holdings Inc. entered into a $40,000,000 equity purchase facility with an institutional investor using a pre-paid purchase structure for its common stock. The initial pre-paid purchase has a $10,730,000 principal amount, a $700,000 original issue discount, and a $30,000 transaction expense payment to the investor.

On the closing, the company receives an initial $10,000,000 plus $1,000,000 for 262,467 registered shares and expects net cash proceeds of $9,727,380 after fees. Additional pre-paid purchases during a commitment period running to as late as April 16, 2028 may carry a 7% original issue discount and 7% annual interest, with a per-share floor price tied to the Nasdaq minimum price.

The investor receives a right to participate in up to 10% of future debt or equity financings and agrees to a weekly sales cap of 15% of the stock’s total weekly dollar trading volume. PMGC’s operating subsidiaries guarantee the obligations, and the facility is secured by pledged equity interests in current and future subsidiaries, supported by a 7,500,000-share reserve for issuances.

PMGC Holdings Inc. reported that its subsidiary AGA Precision Systems has signed a second long-term supply agreement to manufacture aerospace and defense components for a globally recognized Tier 1 customer. The multi-year agreement formalizes an existing relationship and will govern future purchase orders.

The deal underscores AGA’s ITAR-registered and AS9100-certified precision CNC capabilities and its growing role as a qualified supplier in the U.S. defense supply chain. Management highlights that such long-term agreements can support operational visibility and recurring revenue potential, although the customer’s identity and commercial terms are not disclosed.

The company notes that it will provide additional information if the agreement becomes material under securities laws and reminds readers that statements about future performance and benefits are forward-looking and subject to risks described in its recent Annual Report on Form 10-K.

PMGC Holdings Inc. furnished a press release announcing that it has fully utilized the $20 million commitment under its equity purchase facility with Streeterville Capital, LLC, which the company says strengthens its cash position and supports its acquisition strategy.

Management highlights acquisitions completed over 2025 and Q1 2026, including three precision CNC manufacturing businesses serving aerospace, defense, medical and industrial customers, plus a specialty IT packaging company serving over 300 commercial customers in semiconductor, data center and IT supply chains. PMGC intends to focus on organic growth and selective acquisitions aimed at assets that can generate sustainable cash flow and long-term value.

PMGC Holdings Inc., through its wholly owned subsidiary NorthStrive Defense Tech LLC, reported that it has acquired rights to a novel drone technology via an exclusive option agreement. The option covers an exclusive license to certain patent rights under U.S. Patent No. 12,291,334 for a next-generation drone system that moves payloads through water while remaining airborne.

The option also includes a non-exclusive license to related know-how in the aerospace and defense technologies field. During the option period, the Company plans to develop a commercialization plan and seek financing, then negotiate a definitive license agreement if it exercises the option. PMGC cautions there is no guarantee a final license will be executed or that the technology will be successfully developed or commercialized.

PMGC Holdings Inc. is forming a new wholly owned subsidiary, NorthStrive Defense Tech LLC, to focus on defense technology, including drone technology, autonomous systems, and next-generation unmanned defense solutions.

The company plans to use this subsidiary as a platform to identify, acquire, and license advanced defense technologies, initially emphasizing drones and autonomous systems. PMGC aims to leverage its existing subsidiaries, AGA Precision Systems LLC and Silicon Valley Machining, Inc., which already work with aerospace, defense, and space customers, to help commercialize technologies sourced through acquisitions, licensing, and partnerships. The company cautions there is no assurance NorthStrive Defense Tech will successfully secure or commercialize any technologies or generate revenue.

PMGC Holdings Inc., through its wholly owned subsidiary AGA Precision Systems LLC, announced a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products Co., Inc. The agreement establishes a framework governing all purchase orders over an initial five-year term with potential annual renewals.

The company views this deal as strengthening AGA’s role in the aerospace and defense supply chain, including support for programs that may involve U.S. government and defense-related contracts under FAR and DFARS requirements. AGA highlights its AS9100 certification and ITAR compliance as key foundations for serving highly regulated, quality-critical programs.

PMGC Holdings Inc., through its wholly owned subsidiary Northstrive Biosciences Inc., entered into a Third Amendment to its License Agreement with MOA Life Plus Co., Ltd., effective March 24, 2026. The amendment replaces Exhibit C, updating development milestones in the licensed field, including phases for pre-clinical trials, related Investigational New Drug application events, and the timelines for achieving these milestones. PMGC will provide monetary consideration to MOA in connection with entering this amendment, payable upon execution and within 30 days after the effective date.

PMGC Holdings Inc. filed a current report describing a business update at its wholly owned subsidiary, SVM Machining, Inc. dba Silicon Valley Manufacturing. The subsidiary has completed registration under the International Traffic in Arms Regulations (ITAR) and is now in compliance with these U.S. defense export-control standards.

This ITAR registration allows SVM to pursue defense and aerospace programs that specifically require ITAR-compliant suppliers and may improve its standing with Tier 1 defense contractors and aerospace original equipment manufacturers. The development aligns with PMGC’s broader strategy to expand into higher-value, defense-related manufacturing markets while continuing to serve mission-critical industries such as medical technology, aerospace, semiconductor, biotech, pharmaceutical, and transportation.

PMGC Holdings Inc. amended consulting agreements with entities owned by its top leaders, setting new annual fees for 2026. GB Capital Ltd, wholly owned by CEO, CFO and Director Graydon Bensler, will receive an annual consultant fee of $300,000 starting January 1, 2026.

Northstrive Companies Inc., wholly owned by Chairman Braeden Lichti, will receive an annual consultant fee of $360,000 beginning January 1, 2026. All other terms of the existing consulting agreements remain in effect, and the amendments are filed as exhibits to the report.

PMGC Holdings Inc. is implementing a 1-for-6 reverse stock split of its common stock. Every six existing shares are being combined into one share, effective at 12:00 a.m. Eastern time on March 10, 2026. The company anticipates having approximately 3,248,764 shares of common stock outstanding immediately prior to the split and approximately 541,461 shares outstanding immediately after it.

After the amendment, authorized capital will consist of 83,333,334 shares of common stock and 500,000,000 shares of preferred stock, for a total of 583,333,334 authorized shares. The trading symbol remains “ELAB”, the par value is unchanged, and no fractional shares will be issued, with holders receiving one full share in lieu of any fractional position. Outstanding stock awards, options, warrants, and plan reserves are being adjusted proportionally, and the warrants’ exercise prices are being revised to reflect the new share count.

PMGC Holdings Inc. entered into a new secured prepaid equity financing with an investor, referred to as Secured Pre-Paid Purchase #4, on February 6, 2026. The Fourth Pre-Paid Purchase has an original principal amount of $8,147,569.50 with an original issue discount of $692,569.50, resulting in a purchase price of $7,455,000.00.

Most of the purchase price, $6,343,194.44, was deposited into a controlled bank account owned by a new wholly owned subsidiary, ELAB Opportunity Holdings LLC, with the investor holding a first-priority security interest through a Deposit Account Control Agreement. Additional amounts include $651,805.56 to the placement agent, $5,000 to company counsel, and $455,000.00 to a company-designated account.

After the effective date, the investor may require the company to issue and sell common shares at a price equal to 88.00% of the lowest VWAP over the prior ten trading days, up to the outstanding balance, subject to a 9.99% beneficial ownership cap. The company can prepay portions of the balance at 120% of the prepaid amount, while defined events of default trigger immediate cash repayment, a 15.00% increase in the outstanding balance, and interest of up to 18.00% per year. A guaranty from ELAB Opportunity, secured by the controlled deposit account and related funds, supports all obligations under this structure.

PMGC Holdings Inc., through its wholly owned subsidiary NorthStrive Biosciences, announced the filing of ten new U.S. patent applications for its EL-22 and EL-32 technologies targeting animal health and agricultural markets.

The applications cover use of these candidates to encourage muscle growth and increase muscle yield in livestock, aquaculture species, and poultry, along with concepts for reducing gaseous emissions in livestock and mitigating eutrophic conditions in aquaculture. NorthStrive’s lead asset, EL-22, uses an engineered probiotic approach to help preserve muscle during weight loss treatments such as GLP-1 receptor agonists, and this portfolio aims to extend the platform beyond human aesthetics into farmed animal productivity and environmental impact.

PMGC Holdings Inc., through its wholly owned subsidiary Northstrive Biosciences Inc., has signed a definitive, exclusive license agreement with Modulant Biosciences LLC for its EL-22 and EL-32 programs in animal health. Modulant receives a worldwide (excluding Korea), royalty-bearing, sublicensable license to develop, manufacture, and commercialize products derived from these myostatin- and activin-A–targeting probiotic technologies for non-human animal applications, including use as a feed additive. Modulant is responsible for all development, regulatory, manufacturing, and commercialization activities. The agreement converts a previously announced binding term sheet into a full contract, but PMGC cautions there is no assurance Modulant will successfully obtain approvals or commercialize products.

PMGC Holdings Inc., through its subsidiary Northstrive Biosciences, entered into a material license agreement with Modulant Biosciences for non‑human animal health products. Modulant receives an exclusive, royalty-bearing, worldwide license (excluding Korea) to develop and commercialize products using Northstrive’s myostatin and Activin‑A intellectual property.

Northstrive and Modulant will co-own any new intellectual property created under the relationship, each with a half interest. Modulant will share a percentage of commercialization revenue with Northstrive up to a defined threshold, then at a lower rate, and is bound by a broad non‑compete on competing myostatin or Activin‑A products. Human pharmaceutical uses are explicitly excluded, and the agreement includes detailed sublicensing, indemnification, confidentiality, and termination provisions.

PMGC Holdings Inc. completed the acquisition of Machining, Inc., a California precision CNC machining company, on February 2, 2026. PMGC acquired 100% of the shares for a total purchase price of $2,449,148.08, including $2,250,000 in cash, a $130,000 fixed cash balance and a $69,148 net working capital adjustment subject to post-closing true-up.

The seller may earn up to an additional $1,250,000 through two revenue-based earnouts tied to performance in the 12‑month periods ending December 31, 2026 and December 31, 2027. Machining, Inc. generated revenue of $3,042,701 for the year ended December 31, 2024, serving medical, aerospace, semiconductor, biotech, pharmaceutical and transportation markets.

PMGC entered into a short transition services agreement and a lease for the facility, and obtained three‑year non‑compete and non‑solicitation commitments from the seller. The filing also includes audited and unaudited financial statements of Machining, Inc. and pro forma combined financial information.

PMGC Holdings Inc. entered into a third secured pre-paid equity purchase with an institutional investor on January 13, 2026, drawing additional capital under a previously established equity purchase facility. The Third Pre-Paid Purchase has an original principal amount of $5,464,500, issued with a $464,500 original issue discount, resulting in a $5,000,000 initial purchase price to the company and net cash proceeds of $4,562,840 after placement agent fees.

The investor can require PMGC to deliver common shares at a price equal to 88% of the lowest VWAP over ten trading days, up to the outstanding balance, with an option to take cash instead of shares if the share price component falls below $1.05. Issuances are capped so the investor and its affiliates cannot own more than 9.99% of the outstanding common stock. PMGC can prepay all or part of the balance at 120% of the prepaid amount, and detailed default provisions allow the investor to accelerate repayment, increase the balance by 15%, and charge up to 18% annual interest if specified events of default occur.

PMGC Holdings Inc. entered into and closed a second secured pre-paid share purchase with an institutional investor on January 7, 2026. The Second Pre-Paid Purchase has an original principal amount of $3,278,700, including an original issue discount of $278,700, for an initial purchase price to the company of $3,000,000. After paying a placement fee to Univest Securities, LLC and legal expenses, PMGC received net cash proceeds of $2,732,704, with a stated maturity date of January 7, 2029.

The investor can require PMGC to issue shares at a price equal to 88% of the lowest VWAP over the prior 10 trading days, subject to a cash election if the price falls below $1.124. Issuances are capped so the investor and its affiliates cannot own more than 9.99% of outstanding common stock at any time. PMGC may prepay portions of the outstanding balance at 120% of the amount prepaid, and specified default events trigger immediate cash payment of the outstanding balance plus a 15% increase and default interest of up to 18% per year.

PMGC Holdings Inc. reported that on October 30, 2025, it issued a press release that is being furnished as Exhibit 99.1 under Regulation FD. The company notes that this press release, and the information in Item 7.01, are furnished rather than filed, meaning they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings unless specifically referenced.

PMGC Holdings Inc. completed an asset acquisition through subsidiary AGA Precision Systems LLC from Indarg Engineering, Inc. on October 26, 2025. The purchase price was $548,000, paid as $350,000 to discharge the seller’s SBA loan, $28,000 to the seller at closing, and a $170,000 two-year promissory note at 8% secured by the acquired equipment, prepayable at AGA’s option.

AGA will hire the seller’s CEO under an employment agreement with base pay, a signing bonus, a discretionary bonus, and eligibility for incentive compensation tied to net income from transactions the executive directly originates. AGA will offer employment to eligible seller employees. The seller agreed to a two-year non-compete and non-solicitation with customary exceptions, and AGA assumed certain post-closing liabilities tied to assigned contracts and a real property lease, as defined. A press release dated October 28, 2025 was furnished.

PMGC Holdings (ELAB) amended multiple agreements with affiliates of its Non-Employee CEO/CFO and its Non-Employee, Non-Executive Chairman, effective October 16, 2025. The secondment deals with GB Capital Ltd. and Northstrive Companies Inc. now classify seconded staff as exempt or non-exempt, allow participation in company health plans, and add reimbursements for company car use, office space, mobile phones, and onboarding fees. Each secondment includes a fee equal to 30% of aggregate employment costs, and any additions to approved seconded employees require Board approval.

The consulting agreement for the Non-Employee CEO/CFO with GB Capital adds a monthly housing reimbursement of $8,000 for services in Newport Beach and clarifies independent contractor terms, tax responsibilities, non-employee status, non-exclusivity, and authorization to enter contracts subject to Board limits. The consulting agreement for the Non-Executive Chairman with Northstrive similarly clarifies non-employee status, contract authority subject to Board limits, payment through termination, and updates wording from “severance” to “termination.”

PMGC Holdings Inc. (ELAB) disclosed a material transaction in an 8-K that includes several executed transaction documents and specified cash compensation. The filing references a Form of Securities Purchase Agreement, Pre-Paid Purchase, Guaranty, Security Agreement, Pledge Agreement and a Placement Agency Agreement. The company notes $400,000 as cash compensation and $30,000 for expenses. The filing identifies the company’s common stock on The Nasdaq Stock Market and is signed by Chief Executive Officer Graydon Bensler.

PMGC Holdings, Inc. (ticker: ELAB) filed a Certificate of Amendment on September 15, 2025 and submitted the filing on Form 8-K. The company identifies its common stock with $0.0001 par value listed on The Nasdaq Stock Market LLC. The filing cover page lists checkboxes for several communication-related rule categories and attaches Inline XBRL interactive data. The report is signed by Graydon Bensler, who is identified as Chief Executive Officer and Chief Financial Officer.

PMGC Holdings Inc. approved a 3.5-for-1 reverse stock split of its common stock, effective September 2, 2025 at 9:30 a.m. Eastern time. Every 3.5 issued and outstanding shares of common stock were automatically combined into one share, with no action required from stockholders.

Following the change, the company’s authorized common stock became 81,632,654 shares and total authorized capital stock became 581,632,654 shares, including 500,000,000 authorized preferred shares. The common stock continues to trade on The Nasdaq Capital Market under the symbol ELAB, but now carries a new CUSIP number, 73017P300.

No fractional shares were issued; stockholders received one whole share in place of any fractional interest. The company proportionally adjusted the number of shares underlying outstanding stock awards, options, warrants and equity plan reserves, as well as the exercise prices of outstanding warrants, so that these instruments align with the post-split share count.

PMGC Holdings Inc. (ELAB) filed an 8-K reporting arrangements related to warrant inducement transactions. The filing references a Form of New Warrant and a Form of Warrant Inducement Agreement as exhibits and includes an Inline XBRL cover page. The disclosure states a payment of $146,775.30, described as 7% of the aggregate proceeds from the warrant inducement transactions and to cover certain fees and expenses. The document is signed by Graydon Bensler, Chief Executive Officer. Other check-box items and certain contextual details are present in fragmentary form but no earnings, balance sheet figures, or transaction counterparties are provided.

PMGC Holdings, Inc. filed an 8-K reporting amendments to two consulting agreements with Northstrive Companies Inc. (Non-Executive Chairman) and GB Capital Ltd (Non-Employee CEO). The amendments establish a tiered Acquisition Award schedule tied to acquisition value: 5% for $0–$5,000,000; 6% for $5,000,001–$10,000,000; 7% for $10,000,001–$20,000,000; and 8% for acquisition value above $20,000,000.

The filing lists two amendment exhibits and an Inline XBRL cover page file. The document is signed by Graydon Bensler, who is identified as Chief Executive Officer, Chief Financial Officer and Director.

On 25 Jul 2025, PMGC Holdings Inc. (Nasdaq: ELAB) filed an 8-K disclosing a Secondment Agreement with GB Capital Ltd., a company wholly owned by CEO/CFO/director Graydon Bensler. GB Capital will second its employees to PMGC on an exclusive, as-needed basis; the individuals remain GB employees.

Compensation: PMGC will reimburse GB Capital monthly at hourly rates listed in Exhibit A plus pre-approved extraordinary expenses. GB Capital continues to pay salaries and benefits.

Control & Risk Allocation: PMGC assumes full responsibility for the employees’ actions while seconded. The pact includes typical confidentiality, indemnification and liability-limit clauses.

Termination: PMGC may end any employee’s secondment with 15 days’ notice (immediate for misconduct) and may terminate the entire agreement with 30 days’ notice; GB Capital requires 90 days. Either party can terminate on 10 days’ notice for uncured breach.

Governance Note: Because the counterparty is owned by the CEO, this is a related-party transaction; dollar amounts of anticipated reimbursements are not disclosed. No financial results, guidance changes or capital actions were reported. A press release dated 30 Jul 2025 is furnished as Exhibit 99.1.

PMGC Holdings (NASDAQ: ELAB) filed an 8-K report disclosing the release of a press release on June 24, 2025, under Regulation FD. The company, headquartered in Newport Beach, CA, is classified as an emerging growth company.

Key details from the filing:

• Filed under Item 7.01 Regulation FD Disclosure
• The press release is furnished as Exhibit 99.1
• Document signed by Graydon Bensler, serving as CEO, President and Director
• Company has common stock listed on Nasdaq with $0.0001 par value
• Has not elected to use extended transition period for new accounting standards

Note: The specific content of the press release is not detailed in this 8-K filing. The furnished information is explicitly stated as not "filed" under Section 18 of the Exchange Act and not incorporated by reference into future filings unless specifically indicated.